本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

2.12
-0.0500-2.30%
盤後:2.10-0.0200-0.94%19:57 EDT
成交量:260.03萬
成交額:548.54萬
市值:4.11億
市盈率:-2.79
高:2.20
開:2.16
低:2.06
收:2.17
52周最高:6.44
52周最低:2.06
股本:1.94億
流通股本:1.64億
量比:0.78
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:0.87
市盈率(LYR):-2.12

資料載入中...

2026/09/29

重要事件披露

Form 8-K - Current report
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/28

重要事件披露

Form 8-K - Current report
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/24

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/02/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/04

重要事件披露

Form 8-K - Current report